
Weill Cornell Medicine
@weillcornell
Combining excellence & innovation in clinical care, research & education. #CareDiscoverTeach Our Social Media Policy: bit.ly/1vlHtPc
ID: 95972239
http://weill.cornell.edu 10-12-2009 20:01:50
12,12K Tweet
40,40K Takipçi
1,1K Takip Edilen

Preclinical study led by Dr. Vivek Mittal and Dr. Geoffrey Markowitz of Weill Cornell Medicine Cardiothoracic Surgery found that stimulating a key metabolic pathway in T cells can make them work better against tumors when combined with immune checkpoint inhibitor therapy. Full story: bit.ly/4gCy297
